Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Zika virus specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos on the Zika virus.

ZIKA NEWS - Page 2

Zika Virus IgM Detected 12 to 19 Months Following Infection Onset, Study Finds
A new study reports that Zika antibodies persist for longer than initially believed, with antibodies detected in symptomatic patients 18 months after illness onset.
 
A History With Dengue Fever May Provide Some Protection From Symptomatic Zika
Investigators followed a pediatric cohort in Nicaragua over the course of 15 years and found that dengue fever immunity offers some protection against symptomatic Zika disease.
Severe Developmental Impairment Found in 15% of Toddlers Exposed to Zika in Utero
While most infants exposed to Zika in utero show no severe developmental defects, a new study offers an estimate of the impact of Zika-associated impairment within the first 2 years of life.
Prior Dengue Infection in Pregnant Women May Increase Risk of Severe Zika in Their Babies
Two new studies highlight how antibodies from prior infection with Zika or Dengue may increase the severity of illness in the other, impacting the infants of pregnant women who are infected.
Cytokines in Blood of Pregnant Women with Zika May Help Develop Prenatal Screening for Zika-Related Birth Defects
A new study examining cytokines in the blood of pregnant women infected with Zika may help investigators create a screening test for early detection of fetal abnormalities from the virus.
Zika: Where Are We Now?
The virus may be fading from mainstream headlines, but it is active and physicians must stay vigilant.
Health Officials in India Announce Third Zika Outbreak
The Government of India Ministry of Health and Family Welfare has announced 22 confirmed cases of Zika virus in Jaipur as of October 8, 2018.
NIH Launches Clinical Trial for Zika Virus Vaccine Candidate
The NIH has begun a phase 1 trial assessing the safety of rZIKV/D4Δ30-713, a Zika virus vaccine.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?